Abstract
A substantial proportion of the worldwide liver cancer incidence is associated with chronic hepatitis B virus (HBV) infection. The therapeutic management of HBV infections is still problematic and novel antiviral strategies are urgently required. Using the peptide aptamer screening system, we aimed to isolate new molecules, which can block viral replication by interfering with capsid formation. Eight peptide aptamers were isolated from a randomized expression library, which specifically bound to the HBV core protein under intracellular conditions. One of them, named C1-1, efficiently inhibited viral capsid formation and, consequently, HBV replication and virion production. Hence, C1-1 is a novel model compound for inhibiting HBV replication by blocking capsid formation and provides a new basis for the development of therapeutic molecules with specific antiviral potential against HBV infections.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD . 1998 Hepatology 27: 1670–1677
Beasley RP . 1988 Cancer 61: 1942–1956
Blum HE, Zhang Z-S, Galun E, von Weizsäcker F, Garner B, Liang TJ, Wands JR . 1992 J. Virol. 66: 1223–1227
Böttcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K . 1998 EMBO J. 23: 6839–6845
Butz K, Denk C, Ullmann A, Scheffner M, Hoppe-Seyler F . 2000 Proc. Natl. Acad. Sci. USA 97: 6693–6697
Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F . 1995 Oncogene 10: 927–936
Calvert J, Summers J . 1994 J. Virol. 68: 2084–2090
Chang CM, Jeng KS, Hu CP, Lo SJ, Su TS, Ting L-P, Chu C-K, Han S, Pfaff E, Salfeld J, Schaller H . 1987 EMBO J. 6: 675–680
Chevray PM, Nathans D . 1992 Proc. Natl. Acad. Sci. USA 89: 5789–5793
Christianson TW, Sikorski RS, Dante M, Shero JH, Hieter P . 1992 Gene 110: 119–122
Cohen BA, Colas P, Brent R . 1998 Proc. Natl. Acad. Sci. USA 95: 14272–14277
Colas P . 2000 Curr. Opin. Chem. Biol. 4: 54–59
Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R . 1996 Nature 380: 548–550
Conway JF, Cheng N, Zlotnick A, Wingfield TP, Stahl SJ, Steven AC . 1997 Nature 386: 91–94
Crowther RA, Kiselev NA, Böttcher B, Berriman JA, Borisova GP, Ose V, Pumpens P . 1994 Cell 77: 943–950
Cunningham BC, Wells JA . 1997 Curr. Opin. Struct. Biol. 7: 457–462
Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, Crowther L, Condreay LD, Woessner M, Rubin M, Brown NA . 1999 N. Engl. J. Med. 341: 1256–1263
Dyson MR, Murray K . 1995 Proc. Natl. Acad. Sci. USA 92: 2194–2198
Elliott G, O'Hare P . 1999 Gene Therapy 6: 149–151
Fabbrizio E, Le Cam L, Polanowska J, Kaczorek M, Lamb N, Brent R, Sardet C . 1999 Oncogene 18: 4357–4363
Ganem D . 1996 Virology Fields BN, Knipe DM, Howley PM (eds) Lippincott-Raven: Philadelphia pp. 2703–2737
Harlow E, Lane D . 1999 Using Antibodies. A Laboratory Manual Harlow E and Lane D (eds) Cold Spring Harbor Laboratory Press: Cold Spring Harbor pp. 221–265
Hoppe-Seyler F, Butz K . 2000 J. Mol. Med. 78: 426–430
Kolonin MG, Finley RL . 1998 Proc. Natl. Acad. Sci. USA 95: 14266–14271
König S, Beterams G, Nassal M . 1998 J Virol. 72: 4997–5005
Ladner RC . 1995 Trends Biotech. 13: 426–430
Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Wu PC, Dent RC, Barber J, Stephenson SL, Gray DF . 1998 N. Engl. J. Med. 333: 61–68
Lamberts C, Nassal M, Velhagen I, Zentgraf H, Schröder CH . 1993 J. Virol. 67: 3756–3762
Leung D, Abbenante G, Fairlie DP . 2000 J. Med. Chem. 43: 305–340
Pisani P, Parkin DM, Ferlay J . 1993 Int. J. Cancer 54: 594–606
Pisani P, Parkin DM, Munoz N, Ferlay J . 1997 Cancer Epid. Biomark. Prevent. 6: 387–400
Robinson WS . 1994 Annu. Rev. Med. 45: 297–323
Roingeard P, Su SL, Sureau C, Freschlin M, Arbeille B, Essex M, Romet-Lemonne JL . 1990 Hepatology 11: 277–285
Scaglioni P, Melegari M, Takahashi M, Chowdhury JR, Wands J . 1996 Hepatology 24: 1010–1017
Scaglioni PP, Melegari M, Wands J . 1994 Virology 205: 112–120
Seifer M, Standring DN . 1995 Intervirology 38: 47–62
Summers J, Mason B . 1982 Cell 29: 403–415
Summers J, Smith PM, Horwich AL . 1990 J. Virol. 64: 2819–2824
Sureau C, Romet-Lemonne JL, Mullins JI, Essex M . 1986 Cell 7: 37–47
Tuttleman JS, Pourcel C, Summers J . 1986 Cell 47: 451–460
Vidal M, Brachmann RK, Fattaey A, Harlow E, Boeke JD . 1996 Proc. Natl. Acad. Sci. USA 93: 10315–10320
Visintin M, Tse E, Axelson H, Rabbits TH, Cattaneo A . 1999 Proc. Natl. Acad. Sci. USA 96: 11723–11728
von Weizsäcker F, Köck J, Wieland S, Offensperger W-B, Blum HE . 1998 Hepatology 30: 308–315
von Weizsäcker F, Wieland S, Blum HE . 1996 Hepatology 24: 294–299
von Weizsäcker F, Wieland S, Köck J, Offensperger W-B, Offensperger S, Moradpour D, Blum HE . 1997 Hepatology 26: 251–255
Wright TL, Lau YN . 1993 Lancet 342: 1340–1344
Wu T-T, Coates L, Aldrich CE, Summers J, Mason B . 1990 Virology 175: 255–161
Wynne SA, Crowther RA, Leslie AGW . 1999 Mol Cell 3: 771–780
Yaginuma K, Shirakata Y, Kobayashi M, Koike K . 1987 Proc. Natl. Acad. Sci. USA 84: 2678–2682
Zhou S, Standring DN . 1992 Proc. Natl. Acad. Sci. USA 89: 10046–10050
Acknowledgements
We thank H zur Hausen for continuous support. We further thank B Ehret for excellent technical assistance, C Kuhn, H Schaller, S Urban, and H Zentgraf for biological materials, and U Ackermann for photographic work. We also thank S Karpen, S Urban and E Tomai for helpful comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Butz, K., Denk, C., Fitscher, B. et al. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 20, 6579–6586 (2001). https://doi.org/10.1038/sj.onc.1204805
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204805